EP Patent

EP0209689B1 — Use of tetrahydrobiopterins in the preparation of a medicament for the treatment of infantile autism

Assigned to Suntory Ltd · Expires 1992-03-11 · 34y expired

What this patent protects

A pharmaceutical composition for the treatment of infantile autism which contains tetrahydrobiopterin or a derivative thereof as a major effective ingredient and 5-hydroxytryptophan and/or L-DOPA as an optional auxiliary effective ingredient is provided.

USPTO Abstract

A pharmaceutical composition for the treatment of infantile autism which contains tetrahydrobiopterin or a derivative thereof as a major effective ingredient and 5-hydroxytryptophan and/or L-DOPA as an optional auxiliary effective ingredient is provided.

Drugs covered by this patent

sapropterin-dihydrochloride (SAPROPTERIN DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP0209689B1
Jurisdiction: EP
Classification: —
Expires: 1992-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Suntory Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.